BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34657081)

  • 1. Prognostic Impact of LGR5, Prox1, and Notch1 Biomarkers in Stage II to III Colon Cancer.
    Abdelrahman AE; El-Azony A; Elsebai E; Ibrahim HM
    Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):126-135. PubMed ID: 34657081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LGR5 overexpression confers poor relapse-free survival in breast cancer patients.
    Hou MF; Chen PM; Chu PY
    BMC Cancer; 2018 Feb; 18(1):219. PubMed ID: 29471794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow-Cycling Cancer Stem Cells Regulate Progression and Chemoresistance in Colon Cancer.
    Shiokawa D; Sakai H; Ohata H; Miyazaki T; Kanda Y; Sekine S; Narushima D; Hosokawa M; Kato M; Suzuki Y; Takeyama H; Kambara H; Nakagama H; Okamoto K
    Cancer Res; 2020 Oct; 80(20):4451-4464. PubMed ID: 32816913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription Factor PROX1 Suppresses Notch Pathway Activation via the Nucleosome Remodeling and Deacetylase Complex in Colorectal Cancer Stem-like Cells.
    Högström J; Heino S; Kallio P; Lähde M; Leppänen VM; Balboa D; Wiener Z; Alitalo K
    Cancer Res; 2018 Oct; 78(20):5820-5832. PubMed ID: 30154153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch1 functions as a negative regulator of lymphatic endothelial cell differentiation in the venous endothelium.
    Murtomaki A; Uh MK; Choi YK; Kitajewski C; Borisenko V; Kitajewski J; Shawber CJ
    Development; 2013 Jun; 140(11):2365-76. PubMed ID: 23615281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PROX1 Was Associated with LGR5 and Wnt Signaling and Contributed to Poor Prognosis in Gastric Cancer.
    Nakazawa N; Sohda M; Ide M; Shimoda Y; Tateno K; Watanabe T; Sano A; Sakai M; Yokobori T; Ogawa H; Oyama T; Shirabe K; Saeki H
    Oncology; 2022; 100(11):569-575. PubMed ID: 36103842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospero homeobox 1 mediates the progression of gastric cancer by inducing tumor cell proliferation and lymphangiogenesis.
    Park KJ; Cho SB; Park YL; Kim N; Park SY; Myung DS; Lee WS; Kweon SS; Joo YE
    Gastric Cancer; 2017 Jan; 20(1):104-115. PubMed ID: 26759228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
    Sadek SA; A Rehim DM; Fatima S
    Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PROX1 lymphatic density correlates with adverse clinicopathological factors, lymph node metastases and survival in neuroblastomas.
    Ramani P; Norton A; Somerville MS; May MT
    J Neurooncol; 2012 Jul; 108(3):375-83. PubMed ID: 22382784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9.
    Lu MH; Huang CC; Pan MR; Chen HH; Hung WC
    Clin Cancer Res; 2012 Dec; 18(23):6416-25. PubMed ID: 23045246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of stem cell markers CD44 and Lgr5 in colorectal cancer and its relationship with lymph node and liver metastasis].
    Wang XF; Zhang XL; Xu LP; Shi GG; Zheng HY; Sun BC
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2899-2904. PubMed ID: 30293346
    [No Abstract]   [Full Text] [Related]  

  • 14. ERCC1, PARP-1, and AQP1 as predictive biomarkers in colon cancer patients receiving adjuvant chemotherapy.
    Abdelrahman AE; Ibrahim DA; El-Azony A; Alnagar AA; Ibrahim A
    Cancer Biomark; 2020; 27(2):251-264. PubMed ID: 31903985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PROX1 promotes metabolic adaptation and fuels outgrowth of Wnt(high) metastatic colon cancer cells.
    Ragusa S; Cheng J; Ivanov KI; Zangger N; Ceteci F; Bernier-Latmani J; Milatos S; Joseph JM; Tercier S; Bouzourene H; Bosman FT; Letovanec I; Marra G; Gonzalez M; Cammareri P; Sansom OJ; Delorenzi M; Petrova TV
    Cell Rep; 2014 Sep; 8(6):1957-1973. PubMed ID: 25242332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear Notch3 expression is associated with tumor recurrence in patients with stage II and III colorectal cancer.
    Ozawa T; Kazama S; Akiyoshi T; Murono K; Yoneyama S; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kanazawa T; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Morikawa T; Fukayama M; Watanabe T
    Ann Surg Oncol; 2014 Aug; 21(8):2650-8. PubMed ID: 24728738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients.
    AbdelMageed M; Ismail HTH; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer.
    Gzil A; Zarębska I; Jaworski D; Antosik P; Durślewicz J; Maciejewska J; Domanowska E; Skoczylas-Makowska N; Ahmadi N; Grzanka D; Szylberg Ł
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2547-2557. PubMed ID: 32671503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LGR5 expression predicts peritoneal recurrence after curative resection of primary colon cancer.
    Nagata H; Ishihara S; Abe H; Ushiku T; Kishikawa J; Tanaka T; Hata K; Kawai K; Fukayama M; Nozawa H
    Br J Cancer; 2019 May; 120(10):996-1002. PubMed ID: 31000786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and prognostic value of transcription factor PROX1 in colorectal cancer.
    Skog M; Bono P; Lundin M; Lundin J; Louhimo J; Linder N; Petrova TV; Andersson LC; Joensuu H; Alitalo K; Haglund CH
    Br J Cancer; 2011 Oct; 105(9):1346-51. PubMed ID: 21970873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.